Abstract:Qianxue Mou, 1 Ke Yao, 1 Meng Ye, 1 Bowen Zhao, 1 Yuanyuan Hu, 1 Xiaotong Lou, 1 Huixia Li, 2 Hong Zhang, 1 Yin Zhao 1 1 Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2 Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China Correspondence: Hong Zhang Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Correspondence: Yin Zhao Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Purpose: Optic nerve injury (ONI) causes neuroinflammation and neurodegeneration leading to visual deficits. The response of microglia has emerged as an impactful component of etiology in neurodegeneration. This study aimed to investigate the effect of SIRT1-mTORC1 signaling pathway in microglia regulation after ONI. Methods: Cx3Cr1-Cre ERT2 / Raptor F/F and Cx3Cr1-Cre ERT2 / Sirt1 F/F mice were used to delete Raptor and Sirt1 in microglia, respectively. Optic nerve crush (ONC) model was established to mimic ONI. PLX5622, a highly specific inhibitor of the colony-stimulating factor 1 receptor (CSF1R), is used to eliminate microglia in optic nerve. Ionized calcium binding adaptor molecule 1 (Iba1) immunostaining was used to detect microglial activation. Retinal ganglion cells (RGCs) were quantified by Nissl staining and retinal whole-mount immunostaining with RNA-binding protein with multiple splicing (RBPMS). Axonal damage was valued by transmission electron microscopy (TEM). Results: Microglial activation emerged on day 3 post ONC and was earlier than RGCs loss which occurred at day 5 after injury. Depleting microglia with PLX5622 could attenuate the loss of RGCs and axon damage after ONC. Gain- and loss-of-function studies revealed that SIRT1 determined the activation of microglia in optic nerve. In addition, microglia-specific deletion of Raptor resulted in decreased microglial activation. Interestingly, activating mTORC1 with CCT007093 could reverse the function of SIRT1 in regulating the process of microglial activation mediated RGCs loss. Conclusion: Our study reveals a potential novel mechanism of SIRT1-mTORC1 pathway in microglia regulation, and indicates a therapeutic potential for the protection of RGCs in ONI. Keywords: microglia, retinal ganglion cells, optic nerve injury, SIRT1, mTORC1 Diverse pathological states cause degeneration of axons leading to irreversible vision loss, including ocular hypertension, trauma and optic neuritis. 1,2 In these relative diseases, focal axon injury triggers a propagating axon loss and eventually neuronal death. 3 Therefore, axonal injury is thought to be the critical early event for RGCs loss. Multiple glial cell types participate in the process of axonal degeneration after optic nerve injury (ONI), including oligodendroglia, astroglia and microglia. 4–6 The microglia form a population of resident macrophages within the retina and optic nerve. 6,7 In healthy retina, microglia are of vital importance in maintain the normal structure and functioning of the retina. 8 Once activated by noxious insults, microglia can release inflammatory cytokines, such as TNF-α, IL-1β and reactive oxygen species, which could damage RGCs and promote neurodegeneration, and inappropriate phagocytosis by microglia can further accelerate RGCs loss. 9,10 A previous study has shown that microglial activation can aggravate trauma-induced RGCs degeneration, which leads to RGCs loss. 11 Thus, regulation of microglial activation enables microglia to function better as guardians during pathological processes. 12 Besides immune activity, the microglia also participate in the development and maintenance of neural networks, as well as in neurovascular unit homeostasis. 7,13,14 Noteworthy, genetic ablation and/or pharmacological blockade of microglia shows neuroprotective effect in neurodegenerative diseases. 15,16 Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, deacetylates transcription factors, signaling molecules, and histones. 17,18 Resveratrol enhances SIRT1 activity via promoting NADH oxidation to NAD+ and, possibly, by boosting SI -Abstract Truncated-

Inhibition of Mtor Signaling Protects Photoreceptor Cells Against Serum Deprivation by Reducing Oxidative Stress and Inducing G2/M Cell Cycle Arrest.

Inhibiting the Activation of MAPK (ERK1/2) in Stressed Müller Cells Prevents Photoreceptor Degeneration

Mtor Inhibition Attenuates Glucose Deprivation-Induced Death in Photoreceptors Via Suppressing a Mitochondria-Dependent Apoptotic Pathway.

Inhibition of Mtor Signaling by Rapamycin Protects Photoreceptors from Degeneration in Rd1 Mice

Neuroprotective Strategy in Retinal Degeneration: Suppressing ER Stress-Induced Cell Death Via Inhibition of the Mtor Signal

Rapamycin Attenuates Visible Light-Induced Injury in Retinal Photoreceptor Cells Via Inhibiting Endoplasmic Reticulum Stress.

Abnormal Mtorc1 Signaling Leads to Retinal Pigment Epithelium Degeneration.

Rapamycin Inhibits Light-Induced Necrosome Activation Occurring in Wild-Type, but not RPE65-Null, Mouse Retina

Alleviation of Neuronal Energy Deficiency by Mtor Inhibition As a Treatment for Mitochondria-Related Neurodegeneration

Inhibition of Mtor Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia

Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition

Cellular senescence mediates retinal ganglion cell survival regulation post‐optic nerve crush injury

Modulation by SIRT1-mTORC1 Pathway Microglia Pruning Retinal Ganglion Cell Dendrites

Mtor May Interact with PARP-1 to Regulate Visible Light-Induced Parthanatos in Photoreceptors

Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations.

The AMPK-dependent Inhibition of Autophagy Plays a Crucial Role in Protecting Photoreceptor from Photooxidative Injury.

Sirna Targeting Mammalian Target of Rapamycin (mtor) Attenuates Experimental Proliferative Vitreoretinopathy

Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury

Autophagy, Lysosome Dysfunction and Mtor Inhibition in MNU-induced Photoreceptor Cell Damage

RTP801 Immunoreactivity in Retinal Ganglion Cells and Its Down-Regulation in Cultured Cells Protect Them from Light and Cobalt Chloride

Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration